NCT02792686View on ClinicalTrials.gov

ABX464 First in Man Study

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Healthy Volunteers
Interventions
DRUG

ABX464

Single Administration

Trial Locations (1)

Unknown

Centre Cap, Montpellier

Sponsors

Lead Sponsor

Abivax S.A.
All Listed Sponsors
lead

Abivax S.A.

INDUSTRY

NCT02792686 - ABX464 First in Man Study | Biotech Hunter | Biotech Hunter